We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Amgen’s head of R&D, Sean Harper, announced he is stepping down from the big biotech to pursue new opportunities in startups and early-stage companies.